Premier Earnings 2020-12-31

Balance Sheet	Income Statement	Cash Flow
Assets, Equity	Rev, G Profit, Net Income	Ops, Inv, Fin

pinc-20201231

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________________________________________________________________________________

FORM 10-Q

__________________________________________________________________________________________

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2020


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-36092

__________________________________________________________________________________________

Premier, Inc.

(Exact name of registrant as specified in its charter)

___________________________________________________________________________________________


Delaware		35-2477140
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

13034 Ballantyne Corporate Place
Charlotte,	North Carolina	28277
(Address of principal executive offices)		(Zip Code)

(704) 357-0022

(Registrant’s telephone number, including area code)

__________________________________________________________________________________________


Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A Common Stock, $0.01 Par Value	PINC	NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of January 28, 2021, there were 122,238,737 shares of the registrant’s Class A common stock, par value $0.01 per share outstanding.

TABLE OF CONTENTS


		Page
PART I. FINANCIAL INFORMATION		6
Item 1.	Financial Statements	6
	Condensed Consolidated Balance Sheets as of December 31, 2020 and June 30, 2020 (Unaudited)	6
	Condensed Consolidated Statements of Income and Comprehensive Income for the three and six months ended December 31, 2020 and 2019 (Unaudited)	8
	Condensed Consolidated Statements of Stockholders' Equity (Deficit) for the six months ended December 31, 2020 and 2019 (Unaudited)	10
	Condensed Consolidated Statements of Cash Flows for the six months ended December 31, 2020 and 2019 (Unaudited)	12
	Notes to Condensed Consolidated Financial Statements (Unaudited)	13
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	34
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	56
Item 4.	Controls and Procedures	56
PART II. OTHER INFORMATION		57
Item 1.	Legal Proceedings	57
Item 1A.	Risk Factors	57
Item 5.	Other Information	57
Item 6.	Exhibits	58
	Signatures	59

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Statements made in this Quarterly Report that are not statements of historical or current facts, such as those under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements in conditional or future tenses or that include terms such as “believes,” “belief,” “expects,” “estimates,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. Forward-looking statements may include comments as to our beliefs and expectations regarding future events and trends affecting our business and are necessarily subject to uncertainties, many of which are outside our control. Factors that could cause actual results to differ materially from those indicated in any forward-looking statement include, but are not limited to:

•the impact of the continuing financial and operational uncertainty due to the coronavirus pandemic or other pandemics;

•competition which could limit our ability to maintain or expand market share within our industry;

•consolidation in the healthcare industry;

•potential delays recognizing or increasing revenue if the sales cycle or implementation period takes longer than expected;

•the impact on us if members of our group purchasing organization (“GPO”) programs reduce activity levels or terminate or elect not to renew their contracts on substantially similar terms or at all;

•the rate at which the markets for our software as a service (“SaaS”) or licensed-based clinical analytics products and services develop;

•the dependency of our members on payments from third-party payers;

•our reliance on administrative fees that we receive from GPO suppliers;

•our ability to maintain third-party provider and strategic alliances or enter into new alliances;

•our ability to timely offer new and innovative products and services;

•the portion of revenues we receive from our largest members;

•risks and expenses related to future acquisition opportunities and integration of acquisitions;

•financial and operational risks associated with non-controlling investments in other businesses or other joint ventures that we do not control, particularly early-stage companies;

•potential litigation;

•our reliance on Internet infrastructure, bandwidth providers, data center providers and other third parties and our own systems for providing services to our users;

•data loss or corruption due to failures or errors in our systems and service disruptions at our data centers, or breaches or failures of our security measures;

•the financial, operational and reputational consequences of cyber-attacks or other data security breaches that disrupt our operations or result in the dissemination of proprietary or confidential information about us or our members or other third parties;

•our ability to use, disclose, de-identify or license data and to integrate third-party technologies;

•our use of “open source” software;

•our dependency on contract manufacturing facilities located in various parts of the world;

•inventory risk we face in the event of a potential material price decline for the personal protective equipment products we may have purchased at elevated market prices;

•our ability to attract, hire, integrate and retain key personnel;

•adequate protection of our intellectual property and potential claims against our use of the intellectual property of third parties;

•potential sales and use tax liability in certain jurisdictions;

•changes in tax laws that materially impact our tax rate, income tax expense, anticipated tax benefits, deferred tax assets, cash flows and profitability;

•our indebtedness and our ability to obtain additional financing on favorable terms, including our ability to renew or replace our existing long-term credit facility at maturity;

•fluctuation of our quarterly cash flows, revenues and results of operations;

•changes and uncertainty in the political, economic or regulatory environment affecting healthcare organizations, including with respect to the status of the Patient Protection and Affordable Care Act, as amended by the Healthcare and Education Reconciliation Act of 2010;

•our compliance with complex international, federal and state laws governing financial relationships among healthcare providers and the submission of false or fraudulent healthcare claims;

•interpretation and enforcement of current or future antitrust laws and regulations;

•compliance with complex federal and state privacy, security and breach notification laws;

•compliance with current or future laws, rules or regulations adopted by the Food & Drug Administration applicable to our software applications that may be considered medical devices;

•our holding company structure and dependence on distributions from Premier Healthcare Alliance, L.P. (“Premier LP”);

•different interests among our members or between us and our members;

•the ability of our members to exercise significant influence over us;

•the terms of agreements between us and our members;

•the impact of payments required under the Unit Exchange and Tax Receivable Acceleration Agreements (the “Unit Exchange Agreements”) on our overall cash flow and our ability to fully realize the expected tax benefits to match such fixed payment obligations under the Unit Exchange Agreements;

•provisions in our certificate of incorporation and bylaws and provisions of Delaware law that discourage or prevent strategic transactions, including a takeover of us;

•failure to maintain an effective system of internal controls over financial reporting or an inability to remediate any weaknesses identified and the related costs of remediation;

•the impact to us or the price of our Class A common stock if we cease paying dividends or reduce dividend payments from current levels;

•the number of shares of Class A common stock repurchased by us pursuant to any Class A common stock repurchase program and the timing of any such repurchases;

•the number of shares of Class A common stock eligible for sale after the issuance of Class A common stock in our August 2020 restructuring and the potential impact of such sales; and

•the risk factors discussed under the heading “Risk Factors” under Item 1A of our Annual Report on Form 10-K for the fiscal year ended June 30, 2020 (the “2020 Annual Report”), filed with the Securities and Exchange Commission (“SEC”).

More information on potential factors that could affect our financial results is included from time to time in the “Cautionary Note Regarding Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” or similarly captioned sections of this Quarterly Report and our other periodic and current filings made from time to time with the SEC, which are available on our website at http://investors.premierinc.com/ (the contents of which are not part of this Quarterly Report). You should not place undue reliance on any of our forward-looking statements which speak only as of the date they are made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events or otherwise. Furthermore, we cannot guarantee future results, events, levels of activity, performance or achievements.

Certain Definitions

For periods prior to August 11, 2020, references in this Quarterly Report to “member owners” are to the participants in our GPO program that were also limited partners of Premier LP that held Class B Common Units of Premier LP and shares of our Class B Common Stock. For periods on or after August 11, 2020, references in this Quarterly Report to “members” are to healthcare provider participants that participate in our GPO program or utilize any of our programs or services, some of which were formerly referred to as member owners.

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

PREMIER, INC.

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands, except share data)


	December 31, 2020		June 30, 2020
Assets
Cash and cash equivalents	$	109,013	$	99,304
Accounts receivable (net of $1,843 and $731 allowance for doubtful accounts, respectively)	166,438		135,063
Contract assets	239,139		215,660
Inventory	178,346		70,997
Prepaid expenses and other current assets	93,402		97,338
Total current assets	786,338		618,362
Property and equipment (net of $486,689 and $452,609 accumulated depreciation, respectively)	220,569		206,728
Intangible assets (net of $268,623 and $245,160 accumulated amortization, respectively)	395,581		417,422
Goodwill	942,263		941,965
Deferred income tax assets	825,668		430,025
Deferred compensation plan assets	55,035		49,175
Investments in unconsolidated affiliates	148,245		133,335
Operating lease right-of-use assets	52,890		57,823
Other assets	84,210		93,680
Total assets	$	3,510,799	$	2,948,515

Liabilities, redeemable limited partners' capital and stockholders' equity
Accounts payable	$	94,523	$	54,841
Accrued expenses	53,176		53,500
Revenue share obligations	203,763		145,777
Limited partners' distribution payable	—		8,012
Accrued compensation and benefits	59,120		73,262
Deferred revenue	32,491		35,446
Current portion of tax receivable agreements	—		13,689
Current portion of notes payable to members	95,069		—
Line of credit and current portion of long-term debt	105,798		79,560
Other liabilities	60,932		31,987
Total current liabilities	704,872		496,074
Long-term debt, less current portion	5,749		4,640
Tax receivable agreements, less current portion	—		279,981
Notes payable to members, less current portion	347,201		—
Deferred compensation plan obligations	55,035		49,175
Deferred tax liabilities	—		17,508
Deferred consideration, less current portion	83,700		112,917
Operating lease liabilities, less current portion	48,151		52,990
Other liabilities	93,675		75,658
Total liabilities	1,338,383		1,088,943

Commitments and contingencies (Note 16)
Redeemable limited partners' capital	—		1,720,309


	December 31, 2020		June 30, 2020
Stockholders' equity:
Class A common stock, $0.01 par value, 500,000,000 shares authorized; 122,228,635 shares issued and outstanding at December 31, 2020 and 71,627,462 shares issued and outstanding at June 30, 2020	1,222		716
Class B common stock, $0.000001 par value, 600,000,000 shares authorized; 0 and 50,213,098 shares issued and outstanding at December 31, 2020 and June 30, 2020, respectively	—		—

Additional paid-in-capital	2,029,604		138,547
Retained earnings	141,590		—
Total stockholders' equity	2,172,416		139,263
Total liabilities, redeemable limited partners' capital and stockholders' equity	$	3,510,799	$	2,948,515

See accompanying notes to the unaudited condensed consolidated financial statements.

PREMIER, INC.

Condensed Consolidated Statements of Income and Comprehensive Income

(Unaudited)

(In thousands, except per share data)


	Three Months Ended				Six Months Ended
	December 31,				December 31,
	2020		2019		2020		2019
Net revenue:
Net administrative fees	$	145,339	$	172,114	$	277,984	$	344,517
Other services and support	97,818		89,452		196,645		171,338
Services	243,157		261,566		474,629		515,855
Products	179,670		58,040		295,085		106,161
Net revenue	422,827		319,606		769,714		622,016
Cost of revenue:
Services	40,122		47,422		78,872		94,958
Products	171,722		52,819		285,150		96,294
Cost of revenue	211,844		100,241		364,022		191,252
Gross profit	210,983		219,365		405,692		430,764



Operating expenses:
Selling, general and administrative	129,997		86,093		253,951		200,022
Research and development	722		801		1,298		1,180
Amortization of purchased intangible assets	10,260		11,938		23,464		24,982
Operating expenses	140,979		98,832		278,713		226,184
Operating income	70,004		120,533		126,979		204,580
Equity in net income of unconsolidated affiliates	4,572		2,989		10,499		6,596
Interest and investment (loss) income, net	(3,398)		(359)		(5,517)		117
(Loss) gain on FFF put and call rights	(14,507)		30,222		(16,426)		22,383
Other income	4,890		2,747		8,573		3,009
Other (expense) income, net	(8,443)		35,599		(2,871)		32,105
Income before income taxes	61,561		156,132		124,108		236,685
Income tax expense (benefit)	16,657		64,557		(101,481)		74,171
Net income from continuing operations	44,904		91,575		225,589		162,514
Income from discontinued operations, net of tax	—		614		—		1,004
Net income	44,904		92,189		225,589		163,518
Net income from continuing operations attributable to non-controlling interest	(935)		(55,424)		(12,780)		(97,134)
Net income from discontinued operations attributable to non-controlling interest	—		(280)		—		(477)
Net income attributable to non-controlling interest	(935)		(55,704)		(12,780)		(97,611)
Adjustment of redeemable limited partners' capital to redemption amount	—		(480,153)		(26,685)		214,156
Net income attributable to stockholders	$	43,969	$	(443,668)	$	186,124	$	280,063

Comprehensive income:
Net income	44,904		92,189		225,589		163,518
Less: comprehensive income attributable to non-controlling interest	(935)		(55,704)		(12,780)		(97,611)
Comprehensive income attributable to stockholders	$	43,969	$	36,485	$	212,809	$	65,907

Weighted average shares outstanding:
Basic	122,127		64,552		110,851		63,668
Diluted	122,919		64,552		111,573		124,831


	Three Months Ended				Six Months Ended
	December 31,				December 31,
	2020		2019		2020		2019
Earnings per share attributable to stockholders:
Basic earnings per share attributable to stockholders	$	0.36	$	(6.87)	$	1.68	$	4.40
Diluted earnings per share attributable to stockholders	$	0.36	$	(6.87)	$	1.67	$	1.13

See accompanying notes to the unaudited condensed consolidated financial statements.

PREMIER, INC.

Condensed Consolidated Statements of Stockholders' Equity (Deficit)

Six Months Ended December 31, 2020 and 2019

(Unaudited)

(In thousands)


	Class A Common Stock			Class B Common Stock			Treasury Stock			Additional Paid-In Capital		Retained Earnings / (Accumulated Deficit)		Total Stockholders' Equity
	Shares	Amount		Shares	Amount		Shares	Amount
Balance at June 30, 2020	71,627	$	716	50,213	$	—	—	$	—	$	138,547	$	—	$	139,263
Balance at July 1, 2020	71,627	716		50,213	—		—	—		138,547		—		139,263
Impact of change in accounting principle	—	—		—	—		—	—		—		(1,228)		(1,228)
Adjusted balance at July 1, 2020	71,627	716		50,213	—		—	—		138,547		(1,228)		138,035
Exchange of Class B common units for Class A common stock by member owners	70	1		(70)	—		—	—		2,436		—		2,437

Increase in additional paid-in capital related to quarterly exchange by member owners, including associated TRA revaluation	—	—		—	—		—	—		37,319		—		37,319
Increase in additional paid-in capital related to final exchange by member owners, including TRA termination	—	—		—	—		—	—		517,526		—		517,526
Issuance of Class A common stock under equity incentive plan	241	2		—	—		—	—		642		—		644


Stock-based compensation expense	—	—		—	—		—	—		7,229		—		7,229
Repurchase of vested restricted units for employee tax-withholding	—	—		—	—		—	—		(3,023)		—		(3,023)
Net income	—	—		—	—		—	—		—		180,685		180,685
Net income attributable to non-controlling interest	—	—		—	—		—	—		—		(11,845)		(11,845)
Adjustment of redeemable limited partners' capital to redemption amount	—	—		—	—		—	—		—		(26,685)		(26,685)
Reclassification of redeemable limited partners' capital to permanent equity	—	—		—	—		—	—		1,750,840		3,767		1,754,607
Final exchange of Class B common units for Class A common stock by member owners	50,143	502		(50,143)	—		—	—		(502)		—		—
Early Termination Payments to members	—	—		—	—		—	—		(438,967)		—		(438,967)
Dividends ($0.19 per share)	—	—		—	—		—	—		—		(23,381)		(23,381)
Balance at September 30, 2020	122,081	1,221		—	—		—	—		2,012,047		121,313		2,134,581




Issuance of Class A common stock under equity incentive plan	102	1		—	—		—	—		1,770		—		1,771
Issuance of Class A common stock under employee stock purchase plan	45	—		—	—		—	—		1,597		—		1,597

Stock-based compensation expense	—	—		—	—		—	—		7,316		—		7,316
Repurchase of vested restricted units for employee tax-withholding	—	—		—	—		—	—		(28)		—		(28)
Net income	—	—		—	—		—	—		—		44,904		44,904
Net income attributable to non-controlling interest	—	—		—	—		—	—		935		(935)		—

Dividends ($0.19 per share)	—	—		—	—		—	—		—		(23,374)		(23,374)
Adjustment in additional paid-in capital related to consolidated investment	—	—		—	—		—	—		318		(318)		—
Capital Contributions	—	—		—	—		—	—		1,959		—		1,959
Non-controlling interest in consolidated investments	—	—		—	—		—	—		3,690		—		3,690
Balance at December 31, 2020	122,228	$	1,222	—	$	—	—	$	—	$	2,029,604	$	141,590	$	2,172,416


	Class A Common Stock			Class B Common Stock			Treasury Stock			Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ Deficit
	Shares	Amount		Shares	Amount		Shares	Amount
Balance at June 30, 2019	61,938	$	644	64,548	$	—	2,419	$	(87,220)	$	—	$	(775,674)	$	(862,250)
Balance at July 1, 2019	61,938	644		64,548	—		2,419	(87,220)		—		(775,674)		(862,250)
Impact of change in accounting principle	—	—		—	—		—	—		—		(899)		(899)
Adjusted balance at July 1, 2019	61,938	644		64,548	—		2,419	(87,220)		—		(776,573)		(863,149)
Exchange of Class B common units for Class A common stock by member owners	1,311	—		(1,311)	—		(1,311)	47,258		3,534		—		50,792
Redemption of limited partners	—	—		(782)	—		—	—		—		—		—
Increase in additional paid-in capital related to quarterly exchange by member owners, including associated TRA revaluation	—	—		—	—		—	—		12,272		—		12,272
Issuance of Class A common stock under equity incentive plan	485	5		—	—		—	—		1,749		—		1,754
Treasury stock	(1,055)	—		—	—		1,055	(35,649)		—		—		(35,649)
Stock-based compensation expense	—	—		—	—		—	—		3,704		—		3,704
Repurchase of vested restricted units for employee tax-withholding	—	—		—	—		—	—		(8,311)		—		(8,311)
Net income	—	—		—	—		—	—		—		71,329		71,329
Net income attributable to non-controlling interest in Premier LP	—	—		—	—		—	—		—		(41,907)		(41,907)
Adjustment of redeemable limited partners' capital to redemption amount	—	—		—	—		—	—		(12,948)		707,257		694,309
Balance at September 30, 2019	62,679	649		62,455	—		2,163	(75,611)		—		(39,894)		(114,856)
Exchange of Class B units for Class A common stock by member owners	6,873	19		(6,873)	—		(5,031)	164,810		59,117		—		223,946

Increase in additional paid-in capital related to departure and quarterly exchange by member owners, including associated TRA revaluation	—	—		—	—		—	—		1,103		—		1,103
Issuance of Class A common stock under equity incentive plan	146	1		—	—		—	—		4,243		—		4,244
Issuance of Class A common stock under employee stock purchase plan	40	—		—	—		—	—		1,540		—		1,540
Treasury stock	(3,549)	—		—	—		3,549	(112,917)		—		—		(112,917)
Stock-based compensation expense	—	—		—	—		—	—		7,775		—		7,775
Repurchase of vested restricted units for employee tax-withholding	—	—		—	—		—	—		(47)		—		(47)
Net income	—	—		—	—		—	—		—		92,189		92,189
Net income attributable to non-controlling interest in Premier LP	—	—		—	—		—	—		—		(

Price	29.20	EPS	2
Shares	127	P/E	14
MCap	3,698	P/FCF	9
Net Debt	-117	EBIT	306
TEV	3,581	TEV/EBIT	12
TTM 2019-09-30, in MM, except price, ratios

10-Q	2020-12-31	Filed 2021-02-02
10-Q	2020-09-30	Filed 2020-11-03
10-K	2020-06-30	Filed 2020-08-25
10-Q	2020-03-31	Filed 2020-05-06
10-Q	2019-12-31	Filed 2020-02-05
10-Q	2019-09-30	Filed 2019-11-05
10-K	2019-06-30	Filed 2019-08-23
10-Q	2019-03-31	Filed 2019-05-07
10-Q	2018-12-31	Filed 2019-02-06
10-Q	2018-09-30	Filed 2018-11-07
10-K	2018-06-30	Filed 2018-08-23
10-Q	2018-03-31	Filed 2018-05-08
10-Q	2017-12-31	Filed 2018-02-06
10-Q	2017-09-30	Filed 2017-11-07
10-K	2017-06-30	Filed 2017-08-23
10-Q	2017-03-31	Filed 2017-05-10
10-Q	2016-12-31	Filed 2017-02-07
10-Q	2016-09-30	Filed 2016-11-08
10-K	2016-06-30	Filed 2016-08-26
10-Q	2016-03-31	Filed 2016-05-10
10-Q	2015-12-31	Filed 2016-02-09
10-Q	2015-09-30	Filed 2015-11-09
10-K	2015-06-30	Filed 2015-08-26
10-Q	2015-03-31	Filed 2015-05-12
10-Q	2014-12-31	Filed 2015-02-10
10-Q	2014-09-30	Filed 2014-11-12
10-K	2014-06-30	Filed 2014-09-04
10-Q	2014-03-31	Filed 2014-05-13
10-Q	2013-12-31	Filed 2014-02-14
10-Q	2013-09-30	Filed 2013-11-12

8-K	2020-11-02
8-K	2020-09-09
8-K	2020-08-25
8-K	2020-08-05
8-K	2020-07-31
8-K	2020-05-05
8-K	2020-04-24
8-K	2020-02-28
8-K	2020-02-04
8-K	2020-02-04
8-K	2020-01-31
8-K	2020-01-23
8-K	2020-01-14
8-K	2019-12-06
8-K	2019-11-05
8-K	2019-10-31
8-K	2019-10-24
8-K	2019-09-04
8-K	2019-08-20
8-K	2019-08-05
8-K	2019-07-31
8-K	2019-06-14
8-K	2019-06-06
8-K	2019-05-07
8-K	2019-05-06
8-K	2019-04-26
8-K	2019-02-05
8-K	2019-01-31
8-K	2019-01-09
8-K	2018-12-07
8-K	2018-11-09
8-K	2018-11-06
8-K	2018-10-31
8-K	2018-08-21
8-K	2018-07-31
8-K	2018-07-05
8-K	2018-05-07
8-K	2018-04-30
8-K	2018-02-05
8-K	2018-02-02
8-K	2018-01-31
8-K	2018-01-09

EX-10.1	ex101-pincxfy21x1231.htm
EX-31.1	ex311-pincxfy21x1231.htm
EX-31.2	ex312-pincxfy21x1231.htm
EX-32.1	ex321-pincxfy21x1231.htm
EX-32.2	ex322-pincxfy21x1231.htm

PINC 10Q Quarterly Report

Premier Earnings 2020-12-31